Tonix Pharmaceuticals Holding Corp.

NASDAQ: TNXPHealthcare / Drug Manufacturers - Major / USA
1.79+0.2000+12.58%Vol 221 2931Y Perf -96.17%
Jun 18th, 2019 16:00
BID1.70 ASK1.76
Open1.59 Previous Close1.59
Pre-Market- After-Trading1.70
 - -%  -0.09 -5.03%
Target Price
6.67 
Analyst Rating
Strong Buy 1.00
Potencial %
272.63 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)11 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.55 
Earnings Date
12th Aug 2019

Today's Price Range

1.581.79

52wk Range

1.5348.90

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
9.15%
3 Months
-31.94%
6 Months
-25.26%
1 Year
-96.17%
3 Years
-99.09%
5 Years
-99.84%

Name / TickerPriceChg.Chg.%
TNXP1.790.200012.58
AAPL198.454.56002.35
GOOG1 103.6011.10001.02
MSFT135.162.31001.74
XOM75.740.65000.87
WFC46.100.83001.83
JNJ140.230.79000.57
FB188.47-0.5400-0.29
GE10.420.37003.68
JPM110.711.49001.36
Earnings HistoryEstimateReportedSurprise %
Q01 2019-1.28-1.29-0.78
Q04 2018-3.87-6.10-57.62
Q03 2018-6.50-5.7012.31
Q02 2018-7.60-7.303.95
Q01 2018-7.00-8.80-25.71
Q04 2017-7.70-6.7012.99
Q03 2017-6.80-7.00-2.94
Q02 2017-0.73-0.6510.96
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.9990.92Positive
9/2019 QR-0.9690.16Positive
12/2019 FY-4.05--
12/2020 FY-2.69--
Next Report Date12th Aug 2019
Estimated EPS Next Report-0.99
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume221 293
Shares Outstanding (in ths.)6 089
Trades Count390
Dollar Volume366 214
Avg. Volume1 046 923
Avg. Weekly Volume157 624
Avg. Monthly Volume648 806
Avg. Quarterly Volume662 061
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (75.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
1 (25.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.50
Moderate Buy
2.00

Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is focused on delivering an efficacious and safe long-term treatment for PTSD. PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden.

CEO: Seth Lederman

Teplephone: +1 212 980-9155

Address: 509 Madison Avenue, New York 10022, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

55%45%

News